Literature DB >> 21692882

Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease.

Pekka S Miettinen1, Maija Pihlajamäki, Anne M Jauhiainen, Eini Niskanen, Tuomo Hänninen, Ritva Vanninen, Hilkka Soininen.   

Abstract

Medial temporal lobe (MTL) atrophy and posteromedial cortical hypometabolism are consistent imaging findings in Alzheimer's disease (AD). As the MTL memory structures are affected early in the course of AD by neurofibrillary tangle pathology, the posteromedial metabolic abnormalities have been postulated to represent remote effects of MTL alterations. In this study, we investigated with functional MRI (fMRI) the structure-function relationship between the MTL and posteromedial regions, including the retrosplenial, posterior cingulate and precuneal cortices, in 21 older controls (OCs), 18 subjects with amnestic mild cognitive impairment (MCI) and 16 AD patients during a word list learning task. In the voxel-based morphometric and volumetric analyses, the MCI subjects showed smaller entorhinal volume than OCs (P = 0.0001), whereas there was no difference in the hippocampal or posteromedial volume. AD patients, as compared with MCI patients, showed pronounced loss of volume in the entorhinal (P = 0.0001), hippocampal (P = 0.01) and posteromedial (P = 0.001) regions. The normal pattern of posteromedial fMRI task-induced deactivation during active encoding of words was observed bilaterally in the OCs, but only in restricted unilateral left posteromedial areas in the MCI and AD patients. Across all subjects, more extensive impairment of the retrosplenial and posterior cingulate function was significantly related to smaller entorhinal (P = 0.001) and hippocampal (P = 0.0002) volume. These findings demonstrate that entorhinal atrophy and posteromedial cortical dysfunction are early characteristics of prodromal AD, and precede and/or overwhelm atrophy of the hippocampus and posteromedial cortices. Disturbances in posteromedial cortical function are associated with morphological changes in the MTL across the continuum from normal aging to clinical AD. European Journal of Neuroscience
© 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd. No claim to original US government works.

Entities:  

Mesh:

Year:  2011        PMID: 21692882     DOI: 10.1111/j.1460-9568.2011.07745.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

Review 1.  Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?

Authors:  Jiu Chen; Zhijun Zhang; Shijiang Li
Journal:  Neurosci Bull       Date:  2015-01-16       Impact factor: 5.203

2.  Lower hippocampal volume predicts decrements in lane control among drivers with amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Ozioma C Okonkwo; Christopher C Stewart; Luke E Stoeckel; Jan A den Hollander; Jennifer M Elgin; Lindy E Harrell; John C Brockington; David G Clark; Karlene K Ball; Cynthia Owsley; Daniel C Marson; Virginia G Wadley
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-12       Impact factor: 2.680

3.  Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.

Authors:  Maria A de Souza Silva; Bernd Lenz; Andrea Rotter; Teresa Biermann; Oliver Peters; Alfredo Ramirez; Frank Jessen; Wolfgang Maier; Michael Hüll; Johannes Schröder; Lutz Frölich; Stefan Teipel; Oliver Gruber; Johannes Kornhuber; Joseph P Huston; Christian P Müller; Sandra Schäble
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

4.  Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Authors:  Amer M Burhan; Robert Bartha; Christian Bocti; Michael Borrie; Robert Laforce; Pedro Rosa-Neto; Jean-Paul Soucy
Journal:  Alzheimers Res Ther       Date:  2013-07-08       Impact factor: 6.982

5.  Mild Cognitive Impairment Is Not "Mild" at All in Altered Activation of Episodic Memory Brain Networks: Evidence from ALE Meta-Analysis.

Authors:  Pengyun Wang; Juan Li; Hui-Jie Li; Lijuan Huo; Rui Li
Journal:  Front Aging Neurosci       Date:  2016-11-07       Impact factor: 5.750

6.  The effect of hippocampal function, volume and connectivity on posterior cingulate cortex functioning during episodic memory fMRI in mild cognitive impairment.

Authors:  Janne M Papma; Marion Smits; Marius de Groot; Francesco U Mattace Raso; Aad van der Lugt; Henri A Vrooman; Wiro J Niessen; Peter J Koudstaal; John C van Swieten; Frederik M van der Veen; Niels D Prins
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

7.  APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Zan Wang; Zhengjia Dai; Hao Shu; Xuhong Liao; Chunxian Yue; Duan Liu; Qihao Guo; Yong He; Zhijun Zhang
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 8.  A systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new norms.

Authors:  Liesel-Ann C Meusel; Nisha Kansal; Ekaterina Tchistiakova; William Yuen; Bradley J MacIntosh; Carol E Greenwood; Nicole D Anderson
Journal:  Front Aging Neurosci       Date:  2014-07-08       Impact factor: 5.750

9.  Application of calibrated fMRI in Alzheimer's disease.

Authors:  Isabelle Lajoie; Scott Nugent; Clément Debacker; Kenneth Dyson; Felipe B Tancredi; AmanPreet Badhwar; Sylvie Belleville; Yan Deschaintre; Pierre Bellec; Julien Doyon; Christian Bocti; Serge Gauthier; Douglas Arnold; Marie-Jeanne Kergoat; Howard Chertkow; Oury Monchi; Richard D Hoge
Journal:  Neuroimage Clin       Date:  2017-05-16       Impact factor: 4.881

10.  The Pathoconnectivity Profile of Alzheimer's Disease: A Morphometric Coalteration Network Analysis.

Authors:  Jordi Manuello; Andrea Nani; Enrico Premi; Barbara Borroni; Tommaso Costa; Karina Tatu; Donato Liloia; Sergio Duca; Franco Cauda
Journal:  Front Neurol       Date:  2018-01-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.